Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11392)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2014 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Arab JP, Candia R, Zapata R, Muñoz C, Arancibia JP, Poniachik J, Soza A, Fuster F, Brahm J, Sanhueza E, Contreras J, Cuellar MC, Arrese M, Riquelme A. Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review. World J Gastroenterol 2014; 20(34): 12182-12201 [PMID: 25232252 DOI: 10.3748/wjg.v20.i34.12182] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i34/12182.htm |
| Number | Citing Articles |
| 1 |
Yinhua Ni, Fen Zhuge, Mayumi Nagashimada, Tsuguhito Ota. Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis. Nutrients 2016; 8(7): 391 doi: 10.3390/nu8070391
|
| 2 |
Jin-Zhou Zhu, Kelseanna Hollis-Hansen, Xing-Yong Wan, Su-Juan Fei, Xun-Lei Pang, Fan-Dong Meng, Chao-Hui Yu, You-Ming Li. Clinical guidelines of non-alcoholic fatty liver disease: A systematic review. World Journal of Gastroenterology 2016; 22(36): 8226-8233 doi: 10.3748/wjg.v22.i36.8226
|
| 3 |
Juan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares-da-Silva, Francisco Barrera, Carlos Benítez, Marlene Castellanos-Fernandez, Graciela Castro-Narro, Norberto Chavez-Tapia, Daniela Chiodi, Helma Cotrim, Kenneth Cusi, Claudia Pinto Marques Souza de Oliveira, Javier Díaz, Eduardo Fassio, Solange Gerona, Marcos Girala, Nelia Hernandez, Sebastián Marciano, Walter Masson, Nahum Méndez-Sánchez, Nathalie Leite, Adelina Lozano, Martín Padilla, Arturo Panduro, Raymundo Paraná, Edison Parise, Marlene Perez, Jaime Poniachik, Juan Carlos Restrepo, Andrés Ruf, Marcelo Silva, Martín Tagle, Monica Tapias, Kenia Torres, Eduardo Vilar-Gomez, José Eduardo Costa Gil, Adrian Gadano, Marco Arrese. Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. Annals of Hepatology 2020; 19(6): 674 doi: 10.1016/j.aohep.2020.09.006
|
| 4 |
Tian Tian Li, Tian Bi Tan, Hai Qing Hou, Xiao Yun Zhao. Changes in peroxisome proliferator-activated receptor alpha target gene expression in peripheral blood mononuclear cells associated with non-alcoholic fatty liver disease. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0901-7
|
| 5 |
Hong-Tai Chang, Hsiang-Ju Pan, Chien-Hung Lee. Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients. Clinical Breast Cancer 2018; 18(4): e677 doi: 10.1016/j.clbc.2017.11.010
|
| 6 |
Yuan-Ye Qiu, Jing Zhang, Fan-Yi Zeng, Yi Zhun Zhu. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacological Research 2023; 192: 106786 doi: 10.1016/j.phrs.2023.106786
|
| 7 |
Desirée Bartolini, Rita Marinelli, Anna Maria Stabile, Tiziana Frammartino, Angela Guerrini, Stefano Garetto, Jacopo Lucci, Anna Migni, Linda Zatini, Giada Marcantonini, Mario Rende, Francesco Galli. Wheat germ oil vitamin E cytoprotective effect and its nutrigenomics signature in human hepatocyte lipotoxicity. Heliyon 2022; 8(9): e10748 doi: 10.1016/j.heliyon.2022.e10748
|
| 8 |
Guanliang Chen, Yinhua Ni, Naoto Nagata, Liang Xu, Tsuguhito Ota. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2016; 17(9): 1379 doi: 10.3390/ijms17091379
|
| 9 |
Francesco Galli, Angelo Azzi, Marc Birringer, Joan M. Cook-Mills, Manfred Eggersdorfer, Jan Frank, Gabriele Cruciani, Stefan Lorkowski, Nesrin Kartal Özer. Vitamin E: Emerging aspects and new directions. Free Radical Biology and Medicine 2017; 102: 16 doi: 10.1016/j.freeradbiomed.2016.09.017
|
| 10 |
Blanca Martínez Soriano, Antonio Güemes, Guillermo Pola, Azucena Gonzalo, Pilar Palacios Gasós, Ana C. Navarro, Roberto Martínez-Beamonte, Jesús Osada, José J. García. Effect of Melatonin as an Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/7315253
|
| 11 |
Arpita Das, Yu Lung Malcolm Tang, Nora A. Althumiri, Vanessa Garcia-Larsen, Jörn M. Schattenberg, Saleh A. Alqahtani. Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic review. European Journal of Clinical Nutrition 2023; 77(12): 1113 doi: 10.1038/s41430-023-01335-2
|
| 12 |
Desirée Bartolini, Pierangelo Torquato, Carolina Barola, Angelo Russo, Chiara Rychlicki, Danilo Giusepponi, Guido Bellezza, Angelo Sidoni, Roberta Galarini, Gianluca Svegliati-Baroni, Francesco Galli. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E). The Journal of Nutritional Biochemistry 2017; 47: 120 doi: 10.1016/j.jnutbio.2017.06.003
|
| 13 |
Amedeo Lonardo, Silvia Sookoian, Carlos J. Pirola, Giovanni Targher. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 2016; 65(8): 1136 doi: 10.1016/j.metabol.2015.09.017
|
| 14 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. Clínica e Investigación en Arteriosclerosis (English Edition) 2017; 29(4): 185 doi: 10.1016/j.artere.2017.07.001
|
| 15 |
Chunlu Fang, Shujing Liu, Wenqi Yang, Guohua Zheng, Fu Zhou, Xiang Gao, Lian Qin, Guirong Yang, Jiapei Yang, Guangming Zhu, Xinzhuang Wang, Kailing Huang, Xincheng Yang, Yuan Wei, Shuang Peng, Liangming Li. Exercise ameliorates lipid droplet metabolism disorder by the PLIN2–LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(3): 167045 doi: 10.1016/j.bbadis.2024.167045
|
| 16 |
Akihiro Yamauchi, Akiko Kamiyoshi, Teruhide Koyama, Nobuyoshi Iinuma, Shumpei Yamaguchi, Hiroyuki Miyazaki, Eiichi Hirano, Taiichi Kaku, Takayuki Shindo. Placental extract ameliorates non-alcoholic steatohepatitis (NASH) by exerting protective effects on endothelial cells. Heliyon 2017; 3(9): e00416 doi: 10.1016/j.heliyon.2017.e00416
|
| 17 |
Ahmed Abdel-Razik, Nasser Mousa, Walaa Shabana, Mohamed Refaey, Rasha Elzehery, Rania Elhelaly, Khaled Zalata, Mostafa Abdelsalam, Ahmed A. Eldeeb, Mahmoud Awad, Ayman Elgamal, Ahmed Attia, Niveen El-Wakeel, Waleed Eldars. Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot. European Journal of Gastroenterology & Hepatology 2018; 30(10): 1237 doi: 10.1097/MEG.0000000000001232
|
| 18 |
Danilo Giusepponi, Pierangelo Torquato, Desirée Bartolini, Marta Piroddi, Marc Birringer, Stefen Lorkowski, Carmelo Libetta, Gabriele Cruciani, Simone Moretti, Giorgio Saluti, Francesco Galli, Roberta Galarini. Determination of tocopherols and their metabolites by liquid-chromatography coupled with tandem mass spectrometry in human plasma and serum. Talanta 2017; 170: 552 doi: 10.1016/j.talanta.2017.04.030
|
| 19 |
Dimitrios Papandreou, Eleni Andreou. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World Journal of Hepatology 2015; 7(3): 575-582 doi: 10.4254/wjh.v7.i3.575
|
| 20 |
Hironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Ota. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients 2017; 9(4): 387 doi: 10.3390/nu9040387
|
| 21 |
Akihiro YAMAUCHI, Takahiro TONE, Andreia de TOLEDO, Kyoko IGARASHI, Koji SUGIMOTO, Haruka MIYAI, Dawei DENG, Junichi NAKAMURA, Hong Seok LIM, Taiichi KAKU, Eiichi HIRANO, Takayuki SHINDO. Placental extract ameliorates liver fibrosis in a methionine- and choline-deficient diet-induced mouse model of non-alcoholic steatohepatitis. Biomedical Research 2020; 41(1): 1 doi: 10.2220/biomedres.41.1
|
| 22 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (II). Tratamiento de la enfermedad del hígado graso no alcohólico. Clínica e Investigación en Arteriosclerosis 2017; 29(4): 185 doi: 10.1016/j.arteri.2016.06.002
|
| 23 |
|
| 24 |
A. Russo, D. Bartolini, P. Torquato, D. Giusepponi, C. Barola, R. Galarini, M. Birringer, S. Lorkowski, F. Galli. CYP4F2 repression and a modified alpha-tocopherol (vitamin E) metabolism are two independent consequences of ethanol toxicity in human hepatocytes. Toxicology in Vitro 2017; 40: 124 doi: 10.1016/j.tiv.2016.12.014
|
| 25 |
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
|
| 26 |
Juan P Arab, Juan C Claro, Juan P Arancibia, Jorge Contreras, Fernando Gómez, Cristian Muñoz, Leyla Nazal, Eric Roessler, Rodrigo Wolff, Marco Arrese, Carlos Benítez. Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus. World Journal of Hepatology 2016; 8(25): 1075-1086 doi: 10.4254/wjh.v8.i25.1075
|
| 27 |
Lin Xu, Yuanjun Lu, Ning Wang, Yibin Feng. The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder. Antioxidants 2022; 11(5): 922 doi: 10.3390/antiox11050922
|
| 28 |
Katherine J. P. Schwenger, Colin M. Bolzon, Carrie Li, Johane P. Allard. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria. European Journal of Nutrition 2019; 58(5): 1771 doi: 10.1007/s00394-018-1844-5
|
| 29 |
Wanting Yang, Gaoyue Guo, Chao Sun. Therapeutic potential of rifaximin in liver diseases. Biomedicine & Pharmacotherapy 2024; 178: 117283 doi: 10.1016/j.biopha.2024.117283
|
| 30 |
Francisco Pino-de la Fuente, Laura Quezada, Carlos Sepúlveda, Matías Monsalves-Alvarez, Juan M. Rodríguez, Camila Sacristán, Mario Chiong, Miguel Llanos, Alejandra Espinosa, Rodrigo Troncoso. Exercise regulates lipid droplet dynamics in normal and fatty liver. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019; 1864(12): 158519 doi: 10.1016/j.bbalip.2019.158519
|
| 31 |
Nasser Alorfi, Ahmed Ashour. The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry. Diabetes, Metabolic Syndrome and Obesity 2023; : 3115 doi: 10.2147/DMSO.S430740
|
| 32 |
Yong-ho Lee, Jae Hyeon Kim, So Ra Kim, Heung Yong Jin, Eun-Jung Rhee, Young Min Cho, Byung-Wan Lee. Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness. Journal of Korean Medical Science 2017; 32(1): 60 doi: 10.3346/jkms.2017.32.1.60
|
| 33 |
Mikel Ghelfi, Lucas A. Maddalena, Jeffrey A. Stuart, Jeffrey Atkinson, Thad A. Harroun, Drew Marquardt. Vitamin E-inspired multi-scale imaging agent. Bioorganic & Medicinal Chemistry Letters 2019; 29(1): 107 doi: 10.1016/j.bmcl.2018.10.052
|
| 34 |
Shahinul Alam, Thupten Kelsang Lama, Golam Mustafa, Mahabubul Alam, Nooruddin Ahmad. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.71159
|
| 35 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
|
| 36 |
Jeffrey B. Schwimmer, Patricia Ugalde-Nicalo, Jean A. Welsh, Jorge E. Angeles, Maria Cordero, Kathryn E. Harlow, Adina Alazraki, Janis Durelle, Jack Knight-Scott, Kimberly P. Newton, Rebecca Cleeton, Cynthia Knott, Juna Konomi, Michael S. Middleton, Curtis Travers, Claude B. Sirlin, Albert Hernandez, Ahlia Sekkarie, Courtney McCracken, Miriam B. Vos. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys. JAMA 2019; 321(3): 256 doi: 10.1001/jama.2018.20579
|
| 37 |
Sergio Riveros, Martín Inzunza, Fernando Crovari, Eduardo Briceño, Pablo Achurra, Nicolás Quezada. Laparoscopic Revisional Conversion of Sleeve Gastrectomy to Gastric Bypass After Liver Transplantation. Obesity Surgery 2021; 31(5): 2305 doi: 10.1007/s11695-020-05203-x
|
| 38 |
Banafshe Khodami, Behzad Hatami, Zahra Yari, Seyyed Moayyed Alavian, Amir Sadeghi, Hamed Kord Varkaneh, Heitor O. Santos, Azita Hekmatdoost. Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial. European Journal of Clinical Nutrition 2022; 76(7): 987 doi: 10.1038/s41430-022-01081-x
|
| 39 |
Hanaa H. Gaballah, Hemat E. El‐Horany, Duaa S. Helal. Mitigative effects of the bioactive flavonol fisetin on high‐fat/high‐sucrose induced nonalcoholic fatty liver disease in rats. Journal of Cellular Biochemistry 2019; 120(8): 12762 doi: 10.1002/jcb.28544
|